. Inhibition of salivary secretion by lipopolysaccharide: possible role of prostaglandins. Am J Physiol Endocrinol Metab 281: E405-E411, 2001.-Inducible (calcium-independent) nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) are important in the regulation of the function of different organs during infection. A single dose of lipopolysaccharide (LPS; 5 mg/kg ip) within 6 h increased NOS activity (20%) and prostaglandin E (PGE) content (100%) in submandibular glands (SMG) and blocked stimulated salivary secretion in adult male rats. The administration of an iNOS synthesis inhibitor, aminoguanidine (AG), with LPS decreased NOS activity and PGE content. Furthermore, the administration of meloxicam (MLX), an inhibitor of COX-2, blocked the increase in PGE and the production of NO. The incubation of slices of SMG in the presence of 3-morpholinosydnonimine, a donor of NO, increased the release of PGE highly significantly. The incubation of SMG in the presence of a PGE 1 analog (alprostadil) increased the production of NO. These results indicate that LPS activates NOS, leading to NO release, which activates COX, generating PGEs that act back to further activate NOS, causing further generation of PGEs by activation of COX. Because the alprostadil administration inhibited stimulated salivation, LPS-induced inhibition of salivation appears to be caused by increased PGE production. Diminished salivary secretion produces poor oral health; thus the use of COX-2 inhibitors to counteract the effects of inhibited salivation should be considered.
THE SUBMANDIBULAR GLAND (SMG) is one of the major salivary glands, together with the parotid and sublingual glands. The initial saliva is secreted by acini into the terminal end of the ducts and drains into the intercalated ducts, which are succeeded by granular convoluted tubules (GCT). The cells in GCT are characterized by numerous serous-type secretory granules in their cytoplasm. These granules are the repositories of a variety of bioactive substances, including both nerve growth factor and epidermal growth factor and peptidases kallikrein and renin. In the rat, these GCT are succeeded by striated ducts, the appearance of which is due to vertically oriented mitochondria alternating with highly folded plasma membranes. In the rat, the main cells of these ducts are filled with granules. Finally, the striated ducts empty into the excretory ducts (17) .
The secretion of saliva is controlled by the autonomic nervous system. The parasympathetic nervous system is the main controller of this secretion via impulses in the chorda tympani nerve that innervate it and release acetylcholine, which evokes copious salivary secretion by activating muscarinic receptors. The sympathetic nervous system controls salivary secretion by also acting on ␣-and ␤-adrenergic receptors.
Nitric oxide (NO) controls the function of many organs of the body (11, 19) . Nitric oxide synthase (NOS) is present in nerve terminals that are widely distributed in various parts of the SMG (8) . We (10) demonstrated that NO plays a role in the control of salivary secretion. Indeed, we found that inhibition of NOS activity by N G -nitro-L-arginine methyl ester (L-NAME) or N G -monomethyl-L-arginine (L-NMMA) injected intravenously in rats before stimulation of salivary secretion with methacholine (MC) significantly inhibited the secretion of saliva. The SMG contains all three isoforms of NOS: calcium-dependent neural (n)NOS, endothelial (e)NOS, and calcium-independent, inducible NOS (iNOS), as visualized by immunohistochemistry (10) .
Because saliva is the first barrier to the entry of bacteria and viruses into the body, we wished to evaluate the effects of infection, as mimicked by injection of bacterial lipopolysaccharides (LPS), on salivary secretion and on the activity of NOS in the SMG. It is well known that prostaglandins (PGs) also play a very important role in inflammation (18) and are induced by NO, which activates cyclooxygenase (COX) (13) . Therefore, we also evaluated the role of PGs in the response of the gland to LPS. Furthermore, because it has been shown that NO stimulates the release of PGE (14) in the hypothalamus, we decided to study also the possible interaction between NO and PGs in the SMG by the use of specific inhibitors of iNOS and COX-2 in vivo and also by a direct action of a donor of NO on PGE release and of an analog of PGE 1 on NO production by SMG incubates in vitro. Salivary secretion studies. Male Wistar rats (250-300 g) from our own colony were housed under standard conditions (12:12-h light-dark cycle at 22-25°C) and with free access to rat chow and tap water. Food was removed 14 h before experimental procedures to decrease variation in salivary secretion. Salivary responses were determined in anesthetized rats [chloralose 100 mg ⅐ kg Ϫ1 ⅐ 0.5 ml NaCl Ϫ1 (0.9%) iv]. The ducts of the SMG were cannulated, and the different sialogogues were sequentially injected via the right femoral vein, as previously described (1) .
MATERIAL AND METHODS

Chemicals
Effect of LPS and MLX on salivary secretion. To study the effect of LPS on salivary secretion, the rats were injected with LPS (5 mg ⅐ kg Ϫ1 ⅐ 0.5 ml Ϫ1 ip) or NaCl 0.9% (saline) 6 h before cannulation of the duct and measurement of salivary secretion with increasing doses of the different sialogogues such as NA or MC (1, 3, 10, and 30 g/kg in saline). In another series of experiments, the rats were injected with LPS and MLX (0.5 mg ⅐ kg Ϫ1 ⅐ 50 l Ϫ1 im in saline solution) or MLX alone to evaluate the participation of increased PGs due to induction of COX-2 by LPS on salivary secretion.
Effect of nitroglycerine or alprostadil on salivary secretion. To investigate the role of NO or PGE on salivary secretion, rats were injected intravenously with different sialogogues at the same dose every 5 min. MC or NA were injected at a dose of 10 g/kg every 5 min. Nitroglycerine (100 mg/kg iv) or alprostadil (a PGE analog, 2.5 g/kg iv) was injected just before injection of the second pulse of MC or NA. All of the results are expressed as mean weight of saliva secreted per rat (Ϯ SE).
Determination of NOS activity. A modification (2) of the method of Bredt and Snyder, which measures the conversion of [ !4 C]arginine into [ 14 C]citrulline, was used. The method indirectly measures NO production, an index of NOS activity. Because the SMG has an active urea cycle in the tissue, arginine will also be converted to citrulline by this cycle, thereby giving false high values for NOS activity. This problem was obviated by addition of L-valine (25 mM) to the HEPES buffer for homogenization and incubation to block the arginase of the urea cycle. The details of the method used were published previously (10) .
Measurements of PGE content in SMG. PGE content of the SMG was measured by specific RIA as a determinant of COX activity as described elsewhere (3) .
Measurements of radioconversion of [ 14 C]arachidonic acid to prostanoids in SMG. These measurements were performed by chromatography of ethyl acetate extracts and counting of the labeled prostanoids as previously reported (4) . The area of each of the radioactive peaks corresponding to authentic prostanoids was calculated and expressed as a percentage of the total radioactivity of the plates.
In vitro studies. The animals were killed by cervical dislocation, and the salivary glands were removed. One-millimeter-thick sliced SMG were preincubated in Krebs-Ringerbicarbonate buffer medium (pH 7.4) containing 0.1% glucose for 15 min before replacement with fresh medium containing the compounds to be tested. The incubation was continued for 30 min, after which the media were extracted for PGE determination, or the SMG were homogenized for NOS determination.
PGE extraction from incubation media. Incubation media were acidified to pH 3 with 1 N HCl and extracted three times with one volume of ethyl acetate. The extracts were dried in a centrivap at room temperature. These residues were stored at Ϫ70°C until RIA was performed.
Statistics. The statistical evaluation of the salivary secretion studies was performed by calculating the differences in salivation before and after the administration of nitroglycerine or alprostadil to each animal. Each point was evaluated by paired t-test, and P values Յ0.05 were considered statistically significant. For the statistical evaluation for in vitro studies when two groups were compared, Student's t-test was used and P values Յ0.05 were considered statistically significant. In all other studies, comparisons between groups were performed by ANOVA and Student-Newman-Keuls tests, with P values Յ0.05 considered statistically significant. 
RESULTS
Effect of LPS on salivary secretion. Injection of LPS (5 mg/kg ip) to induce endotoxemia produced a highly significant inhibition of salivary secretion stimulated by NE or MC (Fig. 1, A and B) . At a dose of 10 g/kg of NE or MC, LPS reduced salivation 62 and 59%, respectively. At a dose of 30 g/kg, this reduction was 82 and 72%, respectively.
Effect of LPS on SMG NOS activity. Administration of LPS (5 mg/kg) 6 h before the animals were killed induced a 20% increase (P Ͻ 0.05) of NOS activity in the SMG (Fig. 2) .
Effect of LPS on PGE content in SMG. Because we previously found that NO played a stimulatory role in salivary secretion (10), we proposed that there must be another molecule mediating salivary inhibition by LPS; therefore, we focused on a possible role of PGs in salivary secretion. Indeed, LPS injection produced an increase in SMG PGE content detectable at 1 h, and values remained elevated for Յ6 h postinjection (P Ͻ 0.001; Fig. 3) .
Effect of LPS plus AG or MLX on NOS activity in SMG.
Because AG has been shown to be a specific inhibitor of iNOS in vitro (6) and in vivo (21), we injected AG (20 mg/kg ip) 2 min before injection of LPS and measured the activity of NOS in the SMG at the same time (6 h) as for LPS alone (Fig. 2) . In another series of experiments, animals were injected with MLX (0.5 mg/kg im), a known COX-2 inhibitor, or with MLX followed by LPS, as described in Effect of LPS and MLX on salivary secretion. The administration of AG together with LPS prevented the increase of NOS activity (P Ͻ 0.05) compared with the LPS group. MLX unexpectedly also inhibited LPS-stimulated NOS activity.
Effect of LPS and LPS plus AG or MLX on radioimmunoassayable PGE content in SMG.
Injection of LPS dramatically increased PGE content at 6 h by 100% (P Ͻ 0.001; Fig. 4 ). The injection of AG or MLX just before LPS prevented this increase induced by LPS on SMG PGE content.
Effect of LPS and LPS plus AG or MLX on COX as measured by radioconversion of [ 14 C]arachidonic acid to prostanoids by SMG. The radioconversion assay of [
14 C]arachidonic acid that indirectly measures COX activity by measuring arachidonate metabolites such as 6-keto-PGF 1␣ , PGF 2␣ , and PGE 2 gave similar results to those observed when PGE content of the SMG was measured by RIA. The results were expressed as a percentage of total counts per minute of a particular prostanoid on plate per 100 milligrams wet weight of the SMG. The increase in PGE induced by LPS was significantly greater (P Ͻ 0.05) compared with the other groups (Fig. 5) . Similar results were obtained for 6-keto-PGF 2␣ and PGF 1␣ .
Effect of NO on salivary secretion. To determine whether NO itself stimulates salivary secretion, we injected an NO donor, nitroglycerin (100 mg/kg iv). The injection of nitroglycerin alone had no significant effect on salivary secretion; therefore, we used NE or MC as sialogogues. NE or MC was injected at a dose of 10 g/kg every 5 min during 20 min. Nitroglycerin (100 mg/kg) was injected just before the second injection of NE or MC. There was a significant potentiation of salivary outflow by nitroglycerine after administration of NE or MC that was of very short duration and was not significant in the next stimulation (Fig. 6, A and B) .
Effect of a PGE 1 analog on salivary secretion. Because we have found (9) that NO augments stimulated salivary secretion and that the administration of LPS, which increases NOS activity with higher production of NO, paradoxically produced an almost total abolition of stimulated salivary secretion, we hypothesized that this inhibition could be caused by an inhibitory effect of PGs. Therefore, we stimulated salivary secretion by NE or MC, as previously described (10) and injected the PGE 1 analog (alprostadil 2.5 g/kg). The injection of the analog dramatically (P Ͻ 0.01) and irreversibly inhibited the NA-and MC-stimulated salivary secretion (Fig. 7, A and B) .
Cross talk between NO and PGE in SMG. To clarify the possible interaction between NO and PGE, in vitro experiments were performed by incubating sliced SMG in the presence of SIN-1 (a well-known donor of NO), and PGE release was measured. The addition of SIN-1 (300 M) to the incubation media for 30 min increased Ϫ9 M) on NOS activity after 30-min incubation in vitro. Values are means Ϯ SE; n ϭ 6. ***P Ͻ 0.001 vs. control group. Fig. 9 . A: effect of LPS and LPS ϩ MLX on NE-stimulated salivary secretion. Values are means Ϯ SE; n ϭ 7. *P Ͻ 0.05 and ***P Ͻ 0.001 vs. respective control; #P Ͻ 0.05 vs. LPS. B: effect of LPS and LPS ϩ MLX on MCstimulated salivary secretion. Values are means Ϯ SE; n ϭ 8. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 vs. respective control; #P Ͻ 0.05 vs. LPS. the release of PGE (Fig. 8A) . On the other hand, the addition of alprostadil, a PGE 1 analog, significantly increased the activity of NOS (P Ͻ 0.001; Fig. 8B) .
Effect of LPS Ϯ MLX on salivary secretion. After injection of LPS, NE and MC were unable to stimulate salivary secretion, as shown in Fig. 1, A and B . LPS augmented PG production in the SMG, and intravenously injected PGE decreased salivary secretion. In view of these results, we tried to reverse the inhibitory effect of LPS on salivary secretion by coinjecting MLX at the same time. LPS inhibition of salivary secretion could be partially reversed by MLX (Fig. 9, A and B) , but MLX alone had no effect on stimulated salivary secretion. The inhibitory effect of LPS on both NE-and MC-stimulated salivary secretion was reversed only by MLX.
DISCUSSION
The results of our previous research (10) and those reported here establish a role of NO and PGE in salivary secretion in both physiological and pathological conditions. Our previous results showed that inhibitors of NOS such as L-NAME or L-NMMA inhibit salivary secretion induced by muscarinic cholinergic agonists, substance P, NA, and the ␤-adrenergic agonist isoproterenol. These were confirmed by others (12) in another experimental paradigm. Furthermore, in the present study, we found that a donor of NO, nitroglycerine, increases the stimulatory action of sialogogues. NO has a relatively small role, at least in the anesthetized rat, because the effect of nitroglycerine is relatively small and NOS inhibitors only partially reduced the effects of secretagogues. In the pancreas, an organ structurally and functionally similar to the SMG, NO also plays a stimulatory role in the stimulated exocrine secretion (7) .
Because saliva contains many compounds important to combating invading organisms, it was important to study the effect of LPS on salivary secretion. The same dose of LPS shown previously to produce a massive increase in iNOS mRNA and iNOS content in the anterior pituitary and pineal glands (19) increased the number of iNOS-containing macrophages in the SMG and increased total NOS activity (15) . In the present study, although there was an increase in NOS activity in SMG by LPS, the salivary secretion, instead of being increased as we expected, was completely blocked. We found that LPS dramatically increased PGs in SMG as measured by RIA and radioconversion, which showed that there was an increased activity of COX. Because an inhibitor of COX-2 such as MLX blocked this increase by LPS, we suppose that LPS induced COX-2 in the SMG. Furthermore, AG also was able to block the increase in the arachidonate metabolites by LPS. These results are in agreement with many other studies that demonstrated that LPS induces COX-2 (9).
On the other hand, the increase in NOS activity by LPS was accompanied by a complete block of salivation in response to different secretagogues. Furthermore, the PGE 1 analog tested (alprostadil) inhibited salivation induced by NA or MC, confirming previous results (22) . These results are in agreement with others that showed an inhibitory effect of PGs on exocrine pancreatic secretion (16) . There is a similar response of mesenteric vessels to LPS to those of the SMG (VE Mendizabal, A Lomniczi, C Mohn, V Rettori, and E Adler-Graschinsky, unpublished data). Because the mesenteric vessels release NO and PGs into the circulation, a contribution of peripheral production of PGs or NO that reaches the SMG via the circulation should also be considered; however, the concentrations reaching the SMG via the circulation would probably be too low to have an effect.
Finally, we could reduce the inhibitory effect of LPS on NE-or MC-stimulated salivary secretion with a specific inhibitor of COX-2, MLX. Furthermore, AG, a highly selective inhibitor of iNOS synthesis, decreased NOS activity in the gland and reduced the increase in plasma NO 2 /NO 3 induced by LPS (data not shown).
The present results are consistent with the following sequence of events (Fig. 10) . LPS acts on toll-like receptors, as described in the myocardium of rats, mice, and humans (5), on the salivary cells to induce iNOS mRNA synthesis, which increases iNOS. The liberated NO activates COX-2 synthesis, resulting in synthesis and release of PGs, which act back on iNOS-containing cells to augment further iNOS synthesis, which by NO further augments COX-2 synthesis and PG production. Because NO is a weak stimulator of salivary secretion at best, the secreted PGs nearly completely block salivary secretion, leading to the dry mouth that characterizes infection.
There are no previous reports indicating the effect of acute endotoxemia on salivary responses in humans or animals. Here, we report for the first time the effect of LPS and the participation of PGs on salivary responses during systemic inflammation in an animal model. If a dose of AG or MLX can be found to increase salivation during infection, it might be therapeutically useful by decreasing the hyposialosis induced by infection.
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